Showing results (271-280 of 308) with videos related to

Sort By:
Pageof 31
European Journal of Heart Failure|August 19, 2003
Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirinV L Serebruany, A H Glassman, A I Malinin, et al.
Cardiology|April 3, 2015
Aspirin 'resistance': impact on no-reflow, platelet and inflammatory biomarkers in diabetics after ST-segment elevation myocardial infarctionWiktor Kuliczkowski, Mariusz Gasior, Damian Pres, et al.
Nephron|February 26, 2016
Comparison of Three Tests to Distinguish Platelet Reactivity in Patients with Renal Impairment during Dual Antiplatelet TherapyLong Zhe Guo, Moo Hyun Kim, Tae Hyung Kim, et al.
American Heart Journal|December 22, 2005
Valsartan inhibits platelet activity at different doses in mild to moderate hypertensives: Valsartan Inhibits Platelets (VIP) trialVictor L Serebruany, Alex N Pokov, Alex I Malinin, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 11, 2016
Long-term clinical outcomes after successful and failed recanalization to native chronic Total occlusion: Insights from the Busan chronic Total occlusion (B-CTO) RegistryMoo Hyun Kim, Kazuaki Mitsudo, Cai De Jin, et al.
American Heart Journal|April 8, 2003
Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudyVictor L Serebruany, Alex I Malinin, Kevin P Callahan, et al.
Cardiology|November 7, 2016
Troponin I and D-Dimer for Discriminating Acute Pulmonary Thromboembolism from Myocardial InfarctionSoo Jin Kim, Moo Hyun Kim, Kwang Min Lee, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 4, 2014
Contribution of platelets indices in the development of contrast-induced nephropathyIrfan Sahin, Ahmet Karabulut, Ilhan Iker Avci, et al.
American Journal of Therapeutics|May 31, 2019
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting SystemThomas G von Lueder, Dan Atar, Stefan Agewall, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 10, 2003
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trialsVictor L Serebruany, Alexander H Glassman, Alex I Malinin, et al.
Pageof 31